Connelly, Kim A. http://orcid.org/0000-0002-1031-3137
Wu, Ellen
Visram, Aylin
Friedberg, Mark K.
Batchu, Sri Nagarjun
Yerra, Veera Ganesh
Thai, Kerri
Nghiem, Linda
Zhang, Yanling
Kabir, Golam
Desjardins, J. F.
Advani, Andrew
Gilbert, Richard E.
Funding for this research was provided by:
Canada Excellence Research Chairs, Government of Canada
Article History
Accepted: 18 August 2022
First Online: 29 September 2022
Declarations
:
: The study design and protocol were reviewed and approved by the St. Michael’s Hospital Animal care committee.
: Not applicable.
: KAC has received research grants to his institution from Astra Zeneca and Boehringer Ingelheim, received support for travel to scientific meeting from Boehringer Ingelheim and honoraria for speaking engagements and ad hoc participation in advisory boards from Astra Zeneca, Boehringer Ingelheim, and Janssen. REG has received research grants to his institution from Astra Zeneca and Boehringer Ingelheim, received support for travel to scientific meeting from Astra Zeneca and honoraria for speaking engagements and ad hoc participation in advisory boards from Astra Zeneca, Boehringer Ingelheim, and Janssen. A.A. has received research support through his institution from AstraZeneca and Boehringer Ingelheim and KC, REG, and AA are listed as inventors on a patent application by Boehringer Ingelheim on the use of DPP-4 inhibitors in heart failure. All other authors declare no competing interests.